Lv1
80 积分 2025-07-18 加入
Somatostatin receptor subtypes: basic pharmacology and tissue distribution
2个月前
已完结
Selective somatostatin sst2 receptor blockade with the novel cyclic octapeptide, CYN-154806
3个月前
已完结
Control of prostate cancer spheroid growth using 213Bi-labeled multiple targeted α radioimmunoconjugates
4个月前
已完结
[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial
5个月前
已完结
Advances in PSMA-Targeted Radionuclide Therapeutics
5个月前
已完结
First Clinical Results for PSMA-Targeted α-Therapy Using 225Ac-PSMA-I&T in Advanced-mCRPC Patients
5个月前
已完结
Alpha radioligand therapy in neuroendocrine neoplasms: current landscape and spotlight on RYZ101
5个月前
已完结
German Multicenter Study Investigating177Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients
5个月前
已完结
Optimizing [212Pb]Pb-AB001 Radiopharmaceutical Therapy Schedules in PSMA-Positive Subcutaneous Prostate Cancer Xenografts
5个月前
已关闭
Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with 225Ac-PSMA-617: Dosimetry Estimate and Empiric Dose Finding
5个月前
已完结
皖公网安备34019202002308
